FDA Authorizes Cure Alliance Rxperts to Test UC-MSCs
THE CURE ALLIANCE, April 9, 2020 — After a lightening round of proposals and reviews, an international team of scientists led by Dr. Camillo Ricordi was granted immediate FDA authorization for a 24-patient clinical trial to test the safety and exploratory efficacy of umbilical cord-derived mesenchymal stem cells (UC-MSCs) to block the life-threatening lung inflammation that accompanies severe cases of COVID-19. [Read more…]